Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Boxun Medical Biological Instrument has the GF Score of 69, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Shanghai Boxun Medical Biological Instrument GF Score Related Terms
BJSE:920504 vs ISRG, BDX, MDLN: GF Score Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Boxun Medical Biological Instrument GF Score vs Medical Devices & Instruments Industry
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a GF Score of 69 as of Aug. 15, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. This is 109% above median its historical median of 33.00. Over the past decade, Shanghai Boxun Medical Biological Instrument's GF Score has ranged from 26.00 to 60.00.
Is Shanghai Boxun Medical Biological Instrument's GF Score too high?
Shanghai Boxun Medical Biological Instrument's current GF Score of 69 is 109% above median its 10-year median of 33.00. Over the past 10 years, this metric has ranged from a low of 26.00 to a high of 60.00. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's GF Score compare to ISRG and BDX?
Shanghai Boxun Medical Biological Instrument's GF Score of 69 can be compared against companies in the Medical Devices & Instruments industry. Historically, Shanghai Boxun Medical Biological Instrument's own GF Score has ranged from 26.00 to 60.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. Shanghai Boxun Medical Biological Instrument's current GF Score is 69, which is 109% above median its own 10-year median of 33.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Fairly Valued. The stock's GF Value™ is ¥19.41, compared to a current price of ¥17.80 — trading 8.3% below its estimated fair value. The current GF Score is 69, which is 109% above median its 10-year median of 33.00. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current GF Score is 69 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued.
The current stock price of ¥17.80 is trading 8.3% below its estimated GF Value™ of ¥19.41.
GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Fairly Valued.
Key valuation signals for BJSE:920504:
GF Score: 69 (109% above median its 10-year median of 33.00)
GF Value™: ¥19.41 vs. price of ¥17.80 (8.3% below fair value)
No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score
Get the complete analysis for BJSE:920504
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920504 has been successfully added to your 
